ExpreS2ion Biotech Holding AB
| Position | Amount | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2021-03-09 | ExpreS2ion Biotech Holding AB | Keith Alexander | Chief Financial Officer (CFO) | Acquisition | 7 300 | 6,9 | SEK | 50 370 | 2021-03-08 |
| 2021-02-26 | ExpreS2ion Biotech Holding AB | Bent Frandsen | Chief Executive Officer (CEO)/Managing Directory | Acquisition | 6 791 | 6,106 | SEK | 41 465,44 | 2021-02-24 |
| 2021-02-26 | ExpreS2ion Biotech Holding AB | Bent Frandsen | Chief Executive Officer (CEO)/Managing Directory | Acquisition | 1 907 | 5,91 | SEK | 11 270,8 | 2021-02-25 |
| 2021-02-26 | ExpreS2ion Biotech Holding AB | Bent Frandsen | Chief Executive Officer (CEO)/Managing Directory | Disposal | 891 | 5,966 | SEK | 5 315,299 | 2021-02-25 |
| 2021-02-23 | ExpreS2ion Biotech Holding AB | Gitte Pedersen-Botero | Member of the Board of Directors | Acquisition | 1 700 | 14,5 | SEK | 24 650 | 2021-01-14 |
| 2020-11-23 | ExpreS2ion Biotech Holding AB | AR CONSULT ApS | Member of the Board of Directors | Acquisition | 18 300 | 11,207 | SEK | 205 091,76 | 2020-11-18 |
| 2020-11-19 | ExpreS2ion Biotech Holding AB | Allan Rosetzsky | Styrelseledamot/suppleant | Disposal | 27 000 | 18,094 | SEK | 488 548,8 | 2020-09-14 |
| 2020-11-18 | ExpreS2ion Biotech Holding AB | MEDIC ADVICE ApS | Chairman of the Board of Directors | Issue of instrument | 23 145 | 0 | SEK | 0 | 2020-11-16 |
| 2020-11-18 | ExpreS2ion Biotech Holding AB | MEDIC ADVICE ApS | Chairman of the Board of Directors | Issue of instrument | 23 145 | 0 | SEK | 0 | 2020-11-16 |
| 2020-11-18 | ExpreS2ion Biotech Holding AB | MEDIC ADVICE ApS | Chairman of the Board of Directors | Acquisition | 46 291 | 12 | SEK | 555 492 | 2020-10-08 |
| 2020-11-18 | ExpreS2ion Biotech Holding AB | Martin Roland Jensen | Styrelseordförande | Disposal | 69 436 | 0,728 | SEK | 50 549,408 | 2020-10-08 |
| 2020-11-18 | ExpreS2ion Biotech Holding AB | Martin Roland Jensen | Styrelseordförande | Disposal | 140 000 | 0,728 | SEK | 101 920 | 2020-10-11 |
| 2020-11-18 | ExpreS2ion Biotech Holding AB | Bent Frandsen | Chief Executive Officer (CEO)/Managing Directory | Issue of instrument | 19 000 | 0 | SEK | 0 | 2020-11-15 |
| 2020-11-18 | ExpreS2ion Biotech Holding AB | Bent Frandsen | Chief Executive Officer (CEO)/Managing Directory | Issue of instrument | 19 000 | 0 | SEK | 0 | 2020-11-15 |
| 2020-11-18 | ExpreS2ion Biotech Holding AB | AR CONSULT ApS | Member of the Board of Directors | Issue of instrument | 11 100 | 0 | SEK | 0 | 2020-11-15 |
| 2020-11-18 | ExpreS2ion Biotech Holding AB | AR CONSULT ApS | Member of the Board of Directors | Issue of instrument | 11 100 | 0 | SEK | 0 | 2020-11-15 |
| 2020-11-18 | ExpreS2ion Biotech Holding AB | Jakob Knudsen | Member of the Board of Directors | Allotment | 7 000 | 0 | SEK | 0 | 2020-11-15 |
| 2020-11-18 | ExpreS2ion Biotech Holding AB | Jakob Knudsen | Member of the Board of Directors | Allotment | 7 000 | 0 | SEK | 0 | 2020-11-15 |
| 2020-11-18 | ExpreS2ion Biotech Holding AB | Keith Alexander | Chief Financial Officer (CFO) | Issue of instrument | 2 136 | 0 | SEK | 0 | 2020-11-15 |
| 2020-11-18 | ExpreS2ion Biotech Holding AB | Keith Alexander | Chief Financial Officer (CFO) | Issue of instrument | 2 136 | 0 | SEK | 0 | 2020-11-15 |